Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Combined effect of age and severity on the risk of dementia in Parkinson's disease.

Levy G, Schupf N, Tang MX, Cote LJ, Louis ED, Mejia H, Stern Y, Marder K.

Ann Neurol. 2002 Jun;51(6):722-9.

PMID:
12112078
2.

Environmental risk factors for Parkinson's disease: the epidemiologic evidence.

Schoenberg BS.

Can J Neurol Sci. 1987 Aug;14(3 Suppl):407-13. Review.

PMID:
3315146
3.

Re-emergence of childhood stuttering in Parkinson's disease: a hypothesis.

Shahed J, Jankovic J.

Mov Disord. 2001 Jan;16(1):114-8. Review.

PMID:
11215569
4.

Dementia, stroke and Parkinson's disease in Spanish populations: a review of door-to-door prevalence surveys.

del Barrio JL, de Pedro-Cuesta J, Boix R, Acosta J, Bergareche A, Bermejo-Pareja F, Gabriel R, García de Yébenes MJ, García FJ, López-Pousa S, Manubens JM, Mateos R, Matías-Guiu J, Olivé JM, Reñé R, Rodríguez F, Saz P.

Neuroepidemiology. 2005;24(4):179-88. Epub 2005 Apr 12. Review.

5.

Parkinson's disease and risk of mortality: meta-analysis and systematic review.

Xu J, Gong DD, Man CF, Fan Y.

Acta Neurol Scand. 2014 Feb;129(2):71-9. doi: 10.1111/ane.12201. Epub 2013 Nov 20. Review.

PMID:
24256347
6.

[Education, dementia and cerebral reserve].

Carnero-Pardo C.

Rev Neurol. 2000 Sep 16-30;31(6):584-92. Review. Spanish.

PMID:
11055065
7.

[Therapeutic strategies in advanced Parkinson's disease].

Giménez Roldán S.

Neurologia. 1998;13 Suppl 1:49-65. Review. Spanish. No abstract available.

PMID:
9859686
8.

Current concepts on the etiology of Parkinson's disease.

Calne DB.

Mov Disord. 1989;4 Suppl 1:S11-4. Review. No abstract available.

PMID:
2657406
9.

A cumulative genetic risk score predicts progression in Parkinson's disease.

Pihlstrøm L, Morset KR, Grimstad E, Vitelli V, Toft M.

Mov Disord. 2016 Apr;31(4):487-90. doi: 10.1002/mds.26505. Epub 2016 Feb 8. Review.

PMID:
26853697
10.

Standardized quantitative measurements in Parkinson's disease.

Korczyn AD, Giladi N.

Adv Neurol. 1999;80:439-42. Review. No abstract available.

PMID:
10410753
11.

The therapeutic challenges in the older Parkinson's disease patient.

Playfer JR.

Eur J Neurol. 2002 Nov;9 Suppl 3:55-8. Review.

PMID:
12464122
12.

Parkinson's disease perspectives on epidemiology and pathogenesis.

Kessler II.

Prev Med. 1973 Mar;2(1):88-105. Review. No abstract available.

PMID:
4610553
13.

The place of dementia in Parkinson's disease: a methodologic saga.

Mindham RH.

Adv Neurol. 1999;80:403-8. Review. No abstract available.

PMID:
10410748
14.

Tailoring treatment for the Parkinson's disease patient.

Ottley RG, Agbontaen JX, Fodstad H.

JAAPA. 1999 Mar;12(3):54-6, 59-60, 63-6 passim. Review. No abstract available.

PMID:
10728073
15.

[Diagnostic criteria for Parkinson's disease].

Kikuchi S, Moriwaka F, Tashiro K.

Nihon Rinsho. 2000 Oct;58(10):2028-36. Review. Japanese.

PMID:
11068442
16.

The age gap between patients in clinical studies and in the general population: a pitfall for dementia research.

Schoenmaker N, Van Gool WA.

Lancet Neurol. 2004 Oct;3(10):627-30. Review.

PMID:
15380160
17.

Nutrition and Parkinson's disease.

Pandarinath G, Lenhart A.

N C Med J. 1997 May-Jun;58(3):186-8. Review. No abstract available.

PMID:
9164129
18.

Novel movement disorder society-Parkinson's disease criteria: What about SWEDD and genetic forms?

Erro R, Bhatia KP.

Mov Disord. 2016 Mar;31(3):431. doi: 10.1002/mds.26538. Epub 2016 Feb 19. Review. No abstract available.

PMID:
26893229

Supplemental Content

Support Center